(PharmaNewsWire.Com, June 28, 2017 ) Growing number of clinical trials and the higher number of prescription products has been acting as the main driving force for the thin film drug manufacturing market. To further detail about the market’s scope, Market Research Hub (MRH) has recently added a researched report titles as “Thin Film Drug Manufacturing Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2016 – 2024” to its vast report database. According to the research report, the thin film drug manufacturing market is projected to exhibit a CAGR of 9.0% by the end of 2024.
This report initiates with an elaborate executive summary along with a market snapshot and scope that provide overall information of various segments and sub-segments of the market. The study also segregates the global thin film drug manufacturing market with respect to the products type, disease indication, distribution channels, and geographies. On the basis of disease indication, the market is segmented into schizophrenia, migraine, opioid dependence, nausea & vomiting and others. Based on the product type, the thin film drug manufacturing market has been bifurcated into oral thin film, sublingual film, fully dissolving dental/buccal film, transdermal thin film, and others (ocular thin film, etc.). Detailing the distribution channel, the report features hospital pharmacies, drug stores, retail pharmacies, and e- commerce for the time period 2016-2024.
Geographically, the thin film drug manufacturing market has been segmented into major regions consisting of North America, Europe, Asia, Latin America, Middle East and Africa. The analysis shows that the U.S. with around 85.3% share in 2016, dominated the thin film drug manufacturing market in North America. This dominance is marked by technological advancements in pharmaceutical research with rising demand for novel drug delivery. However, the Europe market is saturated and is growing at the slow steady rate; whereas Asia-Pacific is expected to witness the fastest growth with the major contribution of countries such as India, Japan, and China.
The researched study also feature key players operating in the thin film drug manufacturing market. The top players operating in the market include names like Pfizer, Inc., Novartis AG, Solvay, Allergan plc, Wolters Kluwer, IntelGenx Corp., Sumitomo Dainippon Pharma Co. Ltd., Indivior plc and ZIM Laboratories ltd. This study also evaluates the competitive scenario among different market players through market share analysis in the competitive landscape section of the report. The study concludes by providing the factors such as business overview, financial overview, strategic overview and SWOT analysis that has helped market players to take strategic decisions in order to strengthen their positions and expand their shares in the global thin film drug manufacturing market.
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of Pharmaceutical Market Research Reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
